enGene Inc. (ENGN)
NASDAQ: ENGN
· Real-Time Price · USD
3.96
0.10 (2.59%)
At close: Aug 21, 2025, 11:56 AM
enGene Cash Flow Statement
Financials in USD. Fiscal
year is
November - October.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
| Period Ending | Apr 30, 2025 | Jan 31, 2025 | Oct 31, 2024 | Jul 31, 2024 | Apr 30, 2024 | Jan 31, 2024 | Oct 31, 2023 | Jul 31, 2023 | Apr 30, 2023 | Jan 31, 2023 | Oct 31, 2022 | Jul 31, 2022 | Apr 30, 2022 | Dec 31, 2021 |
Net Income | -79.88M | -69.05M | -55.14M | -122.34M | -112.91M | -103.21M | -99.92M | -25.79M | -27.81M | -22.93M | -15.73M | -7.37M | -618.23K | -214.7K |
Depreciation & Amortization | -1.03M | 345K | 323K | 289K | 250K | 209K | 175K | 178K | 188K | 151K | 105K | 53K | n/a | n/a |
Stock-Based Compensation | 7.58M | 6.84M | 5.32M | 7.02M | 5.6M | 3.72M | 3.45M | 128K | 121K | 82K | 62K | 30K | n/a | n/a |
Other Working Capital | -2.93M | -6.66M | -803K | 6.92M | 4.42M | 3.51M | -890K | -2.55M | -1.24M | -42.75K | 1.65M | 90.61K | -289.39K | -574.64K |
Other Non-Cash Items | -1.17M | 164K | 745K | 74.23M | 78.3M | 78.06M | 79.33M | 6M | 2M | 1.95M | 478.64K | 302.64K | -48.36K | -6.91K |
Deferred Income Tax | n/a | n/a | 432K | -3.39M | -8.38M | -7.94M | -7.27M | -1.91M | 3.98M | 3.53M | 2.43M | 884K | n/a | n/a |
Change in Working Capital | -889K | -4.85M | 95K | 8.75M | 1.6M | 3.27M | -517K | -2.01M | 452K | 429.25K | 1.3M | 161.61K | -289.39K | -574.64K |
Operating Cash Flow | -75.39M | -66.61M | -48.28M | -35.49M | -35.61M | -25.89M | -24.74M | -23.39M | -21.07M | -16.79M | -11.36M | -5.93M | -955.98K | -796.25K |
Capital Expenditures | -584K | -718K | -925K | -825K | -980K | -811K | -318K | -214K | -61K | -51K | -38K | -4K | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -108.42M | -94.67M | n/a | n/a | -1.26M | -1.26M | -1.26M | -1.26M | n/a | n/a | -129.66M | -129.66M | -129.66M | -129.66M |
Sales Maturities Of Investments | 41.75M | 10M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -125.03M | -125.03M | -125.03M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -192.28M | -210.41M | -125.95M | -825K | -980K | -811K | -318K | -214K | -61K | -51K | -129.7M | -129.67M | -129.66M | -129.66M |
Debt Repayment | n/a | n/a | 13.05M | 8.71M | 10.72M | 18.72M | 5.67M | 28.41M | 30.4M | 22.4M | 22.4M | 4M | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 262K | 193.57M | 192.51M | 247.69M | 273.18M | 79.43M | 80.48M | 25.25M | -284K | -47K | -37K | 7K | n/a | n/a |
Financial Cash Flow | 60.41M | 253.72M | 265.72M | 256.4M | 283.9M | 98.16M | 86.15M | 53.66M | 30.12M | 22.35M | 153.89M | 135.54M | 131.53M | 131.53M |
Net Cash Flow | -207.26M | -23.3M | 91.48M | 220.08M | 247.31M | 71.46M | 61.09M | 29.58M | 8.52M | 5.05M | 12.37M | -50.44K | 909.56K | 1.07M |
Free Cash Flow | -75.98M | -67.33M | -49.21M | -36.31M | -36.59M | -26.7M | -25.06M | -23.61M | -21.13M | -16.84M | -11.4M | -5.94M | -955.98K | -796.25K |